key: cord-1017609-t8r1wloq
authors: Godoy, Ivan R B; Rodrigues, Tatiane Cantarelli; Skaf, Abdalla
title: Myositis ossificans following COVID-19 vaccination
date: 2021-06-09
journal: QJM
DOI: 10.1093/qjmed/hcab161
sha: 14c226480b0c42196b32477cb5955ac28904199c
doc_id: 1017609
cord_uid: t8r1wloq

nan

Vaccination injection site adverse reactions are common and usually are represented by transitory pain and edema. We present a case of an intramuscular inflammatory nodule related to myositis ossificans following COVID-19 vaccination, and focus on the imaging findings to differentiate with other diagnosis such as muscle edema, abscess and tumors. 4, 5 . In this report we did not performed a muscle biopsy and the temporal link between symptoms and vaccination procedure suggests diagnosis of COVID-19 vaccine-related myositis ossificans as the cause of symptoms. We considered that in addition to minor muscle injury at the site of injection, toxic myopathy may also 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 

Risk of bursitis and other injuries and dysfunctions of the shoulder following vaccinations

COVID-19 vaccine-related myositis

Subacromialsubdeltoid bursitis following COVID-19 vaccination: a case of shoulder injury related to vaccine administration (SIRVA)

Drug-related myopathies of which the clinician should be aware

Toxic and drug-induced myopathies

Neuromuscular presentations in patients with COVID-19